IDH1 and glioblastoma: Furthermore, Notch3 expression was closely associated with poor-prognosis-related GBM subtypes, including IDH1 wild-type, Classical and Mesenchymal subtypes, suggesting that Notch3 may be a promising marker for GBM prognosis.